LMR Partners LLP Purchases Shares of 1,087 HCA Healthcare, Inc. (NYSE:HCA)

LMR Partners LLP purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,087 shares of the company's stock, valued at approximately $326,000.

A number of other hedge funds have also recently added to or reduced their stakes in HCA. Congress Wealth Management LLC DE grew its stake in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares during the last quarter. Evergreen Private Wealth LLC grew its stake in shares of HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after purchasing an additional 35 shares during the last quarter. Mediolanum International Funds Ltd grew its stake in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock valued at $3,153,000 after purchasing an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. grew its stake in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after purchasing an additional 40 shares during the last quarter. Finally, Whittier Trust Co. boosted its stake in shares of HCA Healthcare by 3.6% in the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after buying an additional 41 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

Shares of NYSE HCA traded up $0.02 during trading on Tuesday, reaching $386.91. The company had a trading volume of 261,760 shares, compared to its average volume of 1,428,076. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The stock has a market capitalization of $93.08 billion, a PE ratio of 17.61, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. The stock has a 50-day moving average price of $342.18 and a two-hundred day moving average price of $328.51. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.36 earnings per share. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Royal Bank of Canada decreased their price target on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Robert W. Baird restated a "neutral" rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Bank of America decreased their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Finally, Guggenheim assumed coverage on HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating for the company. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $381.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.